Physician profile
Katherine Gallivan
NPI 1346846581
$2,053.58
in general payments reported to CMS, 2019-2025
17 companies · $439 in 2025
The $439 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $507 · 2022: $341 · 2023: $92.40 · 2024: $675 · 2025: $439.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,206.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,206.30 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $366.05 | 2022-2024 | Farxiga, Andexxa |
| Kestra Medical Technology Services, INC. | $362.42 | 2024-2025 | Assure Wcd |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $227.29 | 2023-2024 | Lifevest |
| Boehringer Ingelheim Pharmaceuticals, INC. | $186.68 | 2021-2025 | Jardiance |
| Glaxosmithkline, LLC. | $154.05 | 2021-2024 | Trelegy Ellipta |
| Janssen Pharmaceuticals, INC | $122.31 | 2024 | Xarelto |
| Esperion Therapeutics, INC. | $120.46 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $114.00 | 2024 | |
| Sanofi-Aventis U.S. LLC | $82.65 | 2022-2023 | |
| Biohaven Pharmaceutical Holding Company Ltd. | $81.97 | 2022 | |
| Merck Sharp & Dohme LLC | $62.94 | 2021 | |
| Impulse Dynamics (USA) INC. | $47.27 | 2024-2025 | Optimizer |
| Biohaven Pharmaceuticals, INC. | $46.06 | 2021 | |
| Solventum Corporation | $24.00 | 2025 | V.A.C.Ulta |
| Novartis Pharmaceuticals Corporation | $21.14 | 2025 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Eisai INC. | $17.28 | 2021 | |
| Boston Scientific Corporation | $17.01 | 2023 | Lux-Dx Insertable Cardiac Monitor |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Katherine Gallivan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.